# National Vaccine Adverse Event Reporting Survey and Etiology

> **NCT05095844** · — · UNKNOWN · sponsor: **Neuroganics LLC** · enrollment: 100000 (estimated)

## Conditions studied

- COVID-19
- Vaccine Adverse Reaction
- Vaccine Reaction
- Vaccine or Biological Substance, Unspecified Causing Adverse Effects in Therapeutic Use
- Corona Virus Infection
- Blood Clot
- Thrombocytopenia
- Neuritis
- Vasculitis
- Influenza
- Guillain-Barré
- GWAS
- Genetic Sequencing

## Interventions

- **BIOLOGICAL:** vaccinated

## Key facts

- **NCT ID:** NCT05095844
- **Lead sponsor:** Neuroganics LLC
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-03-15
- **Primary completion:** 2024-04-01
- **Final completion:** 2024-04-01
- **Target enrollment:** 100000 (ESTIMATED)
- **Last updated:** 2022-03-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05095844

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05095844, "National Vaccine Adverse Event Reporting Survey and Etiology". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05095844. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*